TCCDC') 3

7* wwamoi® jib/LAMA SEQ/U3
UUID: GEEBDCGB- AESB- 4A17- A717- OOBCESFRAéeECDa Sﬁ L daﬂ a! Ail—«Mas Q [(0 b

 

TCGA- VQ -A91Q -01A -PR

gigillll:llllHilllllllllllllllll'liillli 9 919/9

Collect date:

PATHOLOGY REPORT:

PRIMARY SITE: Stomach (Cardia)

I-)Product of esophagogastrectomy:

-Poorly differentiated tubular adenocarcinoma of cardia, with largest tumor size
measuring 6.5 cm.

-Tumor inﬁltrates distal esophagus including adventitia.

—Tumor inﬁltrates stomach wall including perigastric fat.

-Presence of foci of lymphatic invasion and perineural invasion.

-Margin in esophageal adventitia involved by neoplasia.

-Proximal and distal margins uninvolved by neoplasia.

Lymphadenectomy according to standardization:

Right paracardic lymph nodes:
-Metastatic adenocarcinoma (2/2), with capsular invasion.

Left paracardic lymph nodes:
-Metastatic adenocarcinoma (2/2), with capsular invasion.

Lesser curvature lymph nodes:
-Metastatic adenocarcinoma (8/8), with capsular invasion.

Suprapyloric lymph node:
-Uninvolved by neoplasia (0/1).
-Lymphatic neoplastic thrombi in perilymph node fat.

Left gastric artery lymph nodes:
-Metastatic adenocarcinoma (8/8), with capsular invasion.
-Lymphatic neoplastic thrombi in perilymph node fat.

Celiac trunk lymph nodes:
-Metastatic adenocarcinoma (4/6), with capsular invasion.
-Lymphatic neoplastic thrombi in perilymph node fat.

Paraesophageal lymph node:
-Metastatic adenocarcinoma (1/ l ), without capsular invasion.
-Lymphatic neoplastic trombi in perilymph node fat.

ll-)Esophageal margin:
Uninvolved by neoplasia.

III-)Omentum:
Uninvolved by neoplasia.

lV-)Gallbladder:
-Cholelithiasis.

  
  

magnum Dlsucpancy

.umcl Sit:- Disu epanty

 

 

Criteria ﬂ__ﬂ.1.§ﬁ

?iima(y

 

 

 

